TCA-controlled histone succinylation identifies IDH3B as a prognostic and therapeutic target in AML

Clinical Epigenetics · Published 2026-07-05 · DOI 10.1186/s13148-026-02197-8

Free full text

Authors (10)

Minhui Shi, Kepeng Yang, Hao Ding, Na Zhao, Jiewen Ma, Aijie Huang, Yun Wang, Xiaoyu Zhu, Domenico Iuso, Mengqing Gao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Shi, M., Yang, K., Ding, H., et al. (2026). TCA-controlled histone succinylation identifies IDH3B as a prognostic and therapeutic target in AML. Clinical Epigenetics. https://doi.org/10.1186/s13148-026-02197-8

Related articles